Home › Funds › Sofinnova Investments, Inc. › RCUS

Sofinnova Investments, Inc. position in RCUS

ARCUS BIOSCIENCES INC · Health Care

Sofinnova Investments, Inc. reported holding 945,690 shares of RCUS (ARCUS BIOSCIENCES INC) in its Q2 2026 13F filing — a position valued at US$29.2M, representing 1.55% of its reported portfolio and ranking #23 among its reported holdings. Sofinnova Investments, Inc. has disclosed RCUS holdings in 6 of the last 6 reported quarters, going back to Q1 2025.

Latest position (Q2 2026)945.69K sh
Reported value held$29.16M
Portfolio Weight1.55%
First reportedQ1 2025
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Sofinnova Investments, Inc.'s RCUS position evolved

Sofinnova Investments, Inc. first disclosed a stake in RCUS in Q1 2025 at 1,037,776 shares (US$8.1M). The position peaked in Q2 2026 at 945,690 shares, worth US$29.2M. Across 6 filings, Sofinnova Investments, Inc. increased the stake 3 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 945,690 shares valued at US$29.2M — an increase of 22,604 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q1 2025 1.04M $8.15M New
Q2 2025 1.22M $9.90M Add
Q3 2025 1.22M $16.62M Add
Q4 2025 1.10M $26.13M Reduce
Q1 2026 923.09K $19.94M Reduce
Q2 2026 945.69K $29.16M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RCUS and 13F data

RCUS (ARCUS BIOSCIENCES INC) is a Health Care company. 46 other funds we track also report a position in RCUS — the largest reported positions include GILEAD SCIENCES, INC. (US$968.8M), MONTANOVA CAPITAL, LLC (US$147.3M), Siren, L.L.C. (US$74.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RCUS

All RCUS fund holders →

FAQ

How long has Sofinnova Investments, Inc. held RCUS?

Sofinnova Investments, Inc. has disclosed RCUS holdings in 6 of the last 6 reported quarters, going back to Q1 2025.

What is Sofinnova Investments, Inc.'s current position in RCUS?

As of Q2 2026, Sofinnova Investments, Inc. holds 945.69K shares of RCUS (ARCUS BIOSCIENCES INC), valued at $29.16M, representing 1.55% of its reported portfolio and ranking #23.

Has Sofinnova Investments, Inc. been buying or selling RCUS?

In the latest 13F filing (Q2 2026), Sofinnova Investments, Inc. increased its position in RCUS. The position peaked in Q2 2026 at 945.69K shares.

Which other funds hold RCUS?

Other major institutional holders of RCUS include GILEAD SCIENCES, INC., MONTANOVA CAPITAL, LLC, Siren, L.L.C., among 46 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.